Cargando…

Reversal of the anticoagulant and anti-hemostatic effect of low molecular weight heparin by direct prothrombin activation

Lopap, found in the bristles of Lonomia obliqua caterpillar, is the first exogenous prothrombin activator that shows serine protease-like activity, independent of prothrombinase components and unique lipocalin reported to interfere with hemostasis mechanisms. To assess the action of an exogenous pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade, S.A., Carrijo-Carvalho, L.C., Peceguini, L.A.M., Wlian, L., Sato, A.C., Luchiari, C., Silva, E.D., Maffei, F.H.A., Chudzinski-Tavassi, A.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Medicina Tropical 2012
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854179/ https://www.ncbi.nlm.nih.gov/pubmed/22735179 http://dx.doi.org/10.1590/S0100-879X2012007500108

Ejemplares similares

Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin
por: Santos, Roberto P., et al.
Publicado: (2022)

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
por: Riess, H, et al.
Publicado: (2007)

Anticoagulant effect of prothrombin complex concentrates: a whole blood in vitro study
por: Scharbert, G, et al.
Publicado: (2011)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

A Lipocalin-Derived Peptide Modulating Fibroblasts and Extracellular Matrix Proteins
por: Carrijo-Carvalho, Linda Christian, et al.
Publicado: (2012)

rDromaserpin: A Novel Anti-Hemostatic Serpin, from the Salivary Glands of the Hard Tick Hyalomma dromedarii
por: Aounallah, Hajer, et al.
Publicado: (2021)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
por: Grottke, Oliver, et al.
Publicado: (2016)

The role of prothrombin complex concentrates in reversal of target specific anticoagulants
por: Babilonia, Katrina, et al.
Publicado: (2014)

Should we test the prothrombin time in anticoagulated epistaxis patients?
por: Soyka, Michael B., et al.
Publicado: (2013)

Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016)

Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers
por: Nagalla, S, et al.
Publicado: (2016)

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate
por: Bavalia, Roisin, et al.
Publicado: (2020)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
por: Skerritt, Conor, et al.
Publicado: (2014)

Abnormal Prothrombin (PIVKA-II) Expression in Canine Tissues as an Indicator of Anticoagulant Poisoning
por: Maniscalco, Lorella, et al.
Publicado: (2021)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Anticoagulants and the Hemostatic System: A Primer for Occupational Stress Researchers
por: Arble, Eamonn, et al.
Publicado: (2021)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
por: Mar, Philip L., et al.
Publicado: (2019)

Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020)

Anticoagulation Therapy in a Patient With Heterozygous Factor V Leiden and Coexisting Homozygous Prothrombin Gene Mutations
por: Costa, Ryder L, et al.
Publicado: (2020)

Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
por: Noordermeer, Tessa, et al.
Publicado: (2021)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit
por: Silva, Vanessa M., et al.
Publicado: (2020)

Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma
por: DeOcesano-Pereira, Carlos, et al.
Publicado: (2020)

Some hemostatic parameters in women with obstetric hemorrhage in Sokoto, Nigeria
por: Erhabor, O, et al.
Publicado: (2013)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
por: Lindahl, Tomas L., et al.
Publicado: (2017)

A sensitivity comparison of the Quick and Owren prothrombin time methods in oral anticoagulant therapy
por: Horsti, Juha
Publicado: (2009)

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model
por: Honickel, M, et al.
Publicado: (2014)

Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome
por: Pengo, Vittorio, et al.
Publicado: (2020)

Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation
por: Montalvá, Eva, et al.
Publicado: (2022)

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Heparin and Related Drugs: Beyond Anticoagulant Activity
por: Page, Clive
Publicado: (2013)

Not Just Anticoagulation—New and Old Applications of Heparin
por: Zang, Lixuan, et al.
Publicado: (2022)

Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
por: Vargas Hein, O, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_kruhntmjm8eslqvgvaog6tvgb8